Showing results (521-530 of 6,709) with videos related to
Sort By:
Pageof 671
Oncotargets and Therapy|May 22, 2018
Delivery of bevacizumab by intracranial injection: assessment in glioma modelYu-Xiao Liu, Wen-Jia Liu, Hui-Ru Zhang, et al.Oncotargets and Therapy|February 11, 2014
Thoracotomy in refractory gestational trophoblastic neoplasia with lung metastasis after normalization of serum beta human chorionic gonadotropin (β-hCG) with salvage chemotherapyFengzhi Feng, Huiying Hu, Lei Wu, et al.Oncotargets and Therapy|January 22, 2025
Prognostic Value of Pretreatment Carcinoembryonic Antigen (CEA) in Rectal Cancer Treated with Preoperative Short-Course Radiotherapy with Delayed Surgery or Long-Course RadiotherapyYun-Hsuan Lin, Hsuan-Chih Hsu, Eng-Yen HuangOncotargets and Therapy|January 21, 2025
Roles of SPOCK1 in the Formation Mechanisms and Treatment of Non-Small-Cell Lung Cancer and Brain Metastases from Lung CancerXuebing Zhang, Xia Zhang, Hang Yin, et al.Oncotargets and Therapy|March 24, 2025
Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective CohortAsim Farooq, Aatif Amin, Shaarif Bashir, et al.Oncotargets and Therapy|December 4, 2024
Efficacy and Safety of Neoadjuvant Immunotherapy Combined with Sandwich Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Retrospective StudyHuimin Fu, Zetan Chen, Jiawei Chen, et al.Oncotargets and Therapy|December 24, 2024
CRISPR-Cas13a Targeting the FGFR3-TACC3 Fusion Gene Inhibits Proliferation of Bladder Cancer Cells in vitro and in vivoYadong Wang, Jinjin Zhu, Shangwen Liu, et al.Oncotargets and Therapy|November 21, 2024
Four Cases with FUS/CHOP Fusion Gene Products Positive Myxoid Liposarcoma Responding Effectively to Trabectedin MonotherapyHirohito Kirishi, Hiromichi Yamane, Nobuaki Ochi, et al.Oncotargets and Therapy|November 12, 2024
Utilizing Saliva Metabolomics for Diagnosing Gastric Cancer and Exploring the Changes in Saliva Metabolites After SurgeryZhenhua Dong, Qirui Chen, Dingliang Zhao, et al.Pageof 671